Company / Working Capital
ANI Pharmaceuticals, Inc. Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$475.0M
FY2025
5-year range
$234.2M / $475.0M
FY2021-FY2025
Trend
+42.2%
vs FY2024
Sector context
#99 of 213
Health Care
What the data says
At $475M, ANI Pharmaceuticals, Inc.'s working capital ranks #99 of 213 in the Health Care sector. Working Capital has fluctuated over the past 10 years, ranging from -$13M in FY2018 to $475M in FY2025.
Based on SEC 10-K filings.
$475M in FY2025 with a 5-year CAGR of +38.9%.
Improved from $374M to $475M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +24.7%
- 5-Year CAGR
- +38.9%
- 10-Year CAGR
- -
Sector benchmark
#99 of 213 in Health CareTop 46% of 213This company $475.0M Sector average $934.6M
▼
-49.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +38.9%, indicating consistent growth.
- In FY2025, working capital increased 42.2% year-over-year.
- Ranks #99 out of 213 companies in the Health Care sector.
- Lowest working capital in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $475.0M | +42.2% |
| FY2024 | $334.0M | -10.8% |
| FY2023 | $374.3M | +52.9% |
| FY2022 | $244.8M | +4.5% |
| FY2021 | $234.2M | +155.3% |
| FY2020 | $91.8M | -27.2% |
| FY2019 | $126.0M | +1094.5% |
| FY2018 | -$12.7M | -113.7% |
| FY2017 | $92.4M | +30.0% |
| FY2016 | $71.1M | -60.7% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026